These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 9057740)
61. Antiproteinuric effect of Losartan in patients with chronic renal diseases. Zoccali C; Valvo E; Russo D; Panichi V; Zuccala' A Nephrol Dial Transplant; 1997 Jan; 12(1):234-5. PubMed ID: 9027813 [No Abstract] [Full Text] [Related]
62. Haemodynamic and endocrine effects of type 1 angiotensin II receptor blockade in patients with hypoxaemic cor pulmonale. Kiely DG; Cargill RI; Wheeldon NM; Coutie WJ; Lipworth BJ Cardiovasc Res; 1997 Jan; 33(1):201-8. PubMed ID: 9059545 [TBL] [Abstract][Full Text] [Related]
63. Losartan in post-transplant erythrocytosis. Conlon PJ; Smith SR; Butterly DW; Brennan DC Nephrol Dial Transplant; 1996 Dec; 11(12):2524-5. PubMed ID: 9017645 [No Abstract] [Full Text] [Related]
64. [Losartan and the LIFE-study. Antihypertensive treatment with AT1-receptor antagonist]. Kjeldsen SE; Omvik P Tidsskr Nor Laegeforen; 1996 Feb; 116(4):504-7. PubMed ID: 8644056 [TBL] [Abstract][Full Text] [Related]
65. Renal hemodynamics in essential hypertensives treated with losartan. Erley CM; Bader B; Scheu M; Wolf S; Braun N; Risler T Clin Nephrol; 1995 Jan; 43 Suppl 1():S8-11. PubMed ID: 7781206 [TBL] [Abstract][Full Text] [Related]
66. Angiotensin receptors and their antagonists. Goodfriend TL; Elliott ME; Catt KJ N Engl J Med; 1996 Jun; 334(25):1649-54. PubMed ID: 8628362 [No Abstract] [Full Text] [Related]
67. Losartan versus captopril in elderly patients with heart failure. Fournier A; Achard JM; Fernandez LA Lancet; 1997 May; 349(9063):1473-4; author reply 1475. PubMed ID: 9164336 [No Abstract] [Full Text] [Related]
68. [Angiotensin-2 receptor blockade--new therapeutic approach to treatment of hypertension]. Zimlichman R Harefuah; 1996 Jul; 131(1-2):43-5. PubMed ID: 8854479 [No Abstract] [Full Text] [Related]
69. The clinical efficacy and tolerability of the angiotensin II-receptor antagonist losartan in Japanese patients with hypertension. Ogihara T; Yoshinaga K Blood Press Suppl; 1996; 2():78-81. PubMed ID: 8913545 [TBL] [Abstract][Full Text] [Related]
71. Losartan versus captopril in elderly patients with heart failure. Jensen BV; Nielsen SL Lancet; 1997 May; 349(9063):1473; author reply 1475. PubMed ID: 9164335 [No Abstract] [Full Text] [Related]
72. Losartan versus captopril in elderly patients with heart failure. Ball SG Lancet; 1997 May; 349(9063):1474; author reply 1475. PubMed ID: 9164338 [No Abstract] [Full Text] [Related]
73. Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Review of a 25-year experience with 68 cases. Traub YM; Shapiro AP; Rodnan GP; Medsger TA; McDonald RH; Steen VD; Osial TA; Tolchin SF Medicine (Baltimore); 1983 Nov; 62(6):335-52. PubMed ID: 6355755 [TBL] [Abstract][Full Text] [Related]
74. Rationale for the chemical development of angiotensin II receptor antagonists. Wexler RR; Carini DJ; Duncia JV; Johnson AL; Wells GJ; Chiu AT; Wong PC; Timmermans PB Am J Hypertens; 1992 Dec; 5(12 Pt 2):209S-220S. PubMed ID: 1290616 [TBL] [Abstract][Full Text] [Related]
75. [Angiotensin II receptor antagonists]. Bornkessel B Med Monatsschr Pharm; 1995 Jun; 18(6):148-51. PubMed ID: 7609710 [No Abstract] [Full Text] [Related]
76. Losartan and angina pectoris. Ahmad S Tex Heart Inst J; 1995; 22(4):347-8. PubMed ID: 8605440 [No Abstract] [Full Text] [Related]
77. Angiotensin II AT1 receptor antagonists. Clinical implications of active metabolites. Schmidt B; Schieffer B J Med Chem; 2003 Jun; 46(12):2261-70. PubMed ID: 12773029 [No Abstract] [Full Text] [Related]
78. Antihypertensive and anti-albuminuric effects of losartan potassium and felodipine in Chinese elderly hypertensive patients with or without non-insulin-dependent diabetes mellitus. Chan JC; Critchley JA; Tomlinson B; Chan TY; Cockram CS Am J Nephrol; 1997; 17(1):72-80. PubMed ID: 9057957 [TBL] [Abstract][Full Text] [Related]
79. [Medical angiotensin II-receptor blockade in hypertension and heart failure]. van Zwieten PA; Lie KI Ned Tijdschr Geneeskd; 1995 Jul; 139(30):1529-33. PubMed ID: 7675129 [No Abstract] [Full Text] [Related]
80. Benefit of angiotensin II receptor blockade in the treatment of posttransplant polycythemia in renal transplant recipients. Kupin W; Venkat KK; Goggins M; Abouljoud M; Escobar F; Mozes M Transplant Proc; 1997; 29(1-2):207-8. PubMed ID: 9122965 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]